BRIEF published on 04/16/2025 at 07:35, 11 months 12 days ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
PRESS RELEASE published on 04/16/2025 at 07:30, 11 months 12 days ago Inside Information / Other news releases Sensorion to host a symposium at ISIET's International Conference on Inner Ear Therapies in Marrakech, Morocco, on April 26, 2025, focusing on hearing loss innovation and gene therapies Sensorion Gene Therapies Symposium ISIET Inner Ear Therapies
BRIEF published on 04/02/2025 at 07:35, 11 months 26 days ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 11 months 26 days ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 1 year ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 1 year ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
Published on 03/28/2026 at 01:00, 9 hours 1 minute ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 9 hours 6 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 9 hours 11 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 11 hours 16 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 11 hours 31 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 08:56, 1 hour 5 minutes ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 8 hours 19 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 12 hours 3 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 13 hours 53 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 14 hours 31 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 18:52, 15 hours 9 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 15 hours 21 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 16 hours 8 minutes ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 16 hours 16 minutes ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
